Literature DB >> 16443711

Clinical importance of the Step 3 choice in asthma.

M L Barnes, B J Lipworth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16443711      PMCID： PMC2104568          DOI： 10.1136/thx.2005.055632

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  3 in total

Review 1.  Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma.

Authors:  M Masoli; M Weatherall; S Holt; R Beasley
Journal:  Thorax       Date:  2005-09       Impact factor: 9.139

2.  Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA).

Authors:  S Shrewsbury; S Pyke; M Britton
Journal:  BMJ       Date:  2000-05-20

3.  Effects of fluticasone plus salmeterol versus twice the dose of fluticasone in asthmatic patients.

Authors:  Graeme P Currie; Caroline E Bates; Daniel K C Lee; Catherine M Jackson; Brian J Lipworth
Journal:  Eur J Clin Pharmacol       Date:  2003-03-22       Impact factor: 2.953
  3 in total
  1 in total

Review 1.  Long-acting beta2-agonists in asthma: not so SMART?

Authors:  Graeme P Currie; Daniel K C Lee; Brian J Lipworth
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.